PHASE-II STUDY OF CARBOPLATIN IN RECURRENT OVARIAN-CANCER - SEVERE HEMATOLOGIC TOXICITY IN PREVIOUSLY TREATED PATIENTS

被引：22

作者：

COLOMBO, N

SPEYER, JL

GREEN, M

CANETTA, R

BELLER, U

WERNZ, JC

MEYERS, M

WIDMAN, T

BLUM, RH

PICCART, M

MUGGIA, FM

BECKMAN, EM

机构：

[1] NYU MED CTR,DIV ONCOL,OLD BELLEVUE ADM BLDG,462 1ST AVE,ROOM 224,NEW YORK,NY 10016

[2] NYU MED CTR,DIV GYNECOL ONCOL,NEW YORK,NY 10016

[3] RITA & STANLEY H KAPLAN CANC CTR,NEW YORK,NY

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 23卷 / 05期

关键词：

D O I：

10.1007/BF00292413

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：323 / 328

页数：6

共 10 条

[1] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

JONES, AC ;

MCELWAIN, TJ ;

RAJU, S ;

WILTSHAW, E ;

SMITH, IE ;

BAKER, JM ;

PECKHAM, MJ ;

HARRAP, KR .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147

[2]

EGORIN MJ, 1984, CANCER RES, V44, P5432

[3]

EGORIN MJ, 1985, CANCER RES, V45, P6502

[4]

EISENHAUER EA, 1986, CANCER TREAT REP, V70, P1195

[5]

EVANS BD, 1983, CANCER TREAT REP, V67, P997

[6]

GAVER RC, 1987, P AM ASSOC CANC RES, V28, P195

[7]

LEYVRAZ S, 1985, J CLIN ONCOL, V3, P1385, DOI 10.1200/JCO.1985.3.10.1385

[8]

PRIEGO V, 1983, P AM SOC CLIN ONCOL, V24, P30

[9] PHASE-I STUDY OF CARBOPLATIN GIVEN ON A 5-DAY INTRAVENOUS SCHEDULE [J].

ROZENCWEIG, M ;

NICAISE, C ;

BEER, M ;

CRESPEIGNE, N ;

VANRIJMENANT, M ;

LENAZ, L ;

KENIS, Y .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (10) :621-626

[10]

WILTSHAW E, 1985, P AN M AM SOC CLIN, V4, P121

← 1 →